Geode Capital Management, LLC Bio Xcel Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.07 Trillion
  • Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 457,920 shares of BTAI stock, worth $586,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
457,920
Previous 450,227 1.71%
Holding current value
$586,137
Previous $1.33 Million 2.79%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$1.95 - $4.04 $15,001 - $31,079
7,693 Added 1.71%
457,920 $1.29 Million
Q4 2023

Feb 13, 2024
BUY
$2.32 - $5.51 $62,888 - $149,359
27,107 Added 6.41%
450,227 $1.33 Million
Q3 2023

Nov 13, 2023
BUY
$2.49 - $11.85 $45,990 - $218,869
18,470 Added 4.56%
423,120 $1.07 Million
Q2 2023

Aug 11, 2023
BUY
$6.39 - $28.58 $137,519 - $615,070
21,521 Added 5.62%
404,650 $2.69 Million
Q1 2023

May 15, 2023
BUY
$17.7 - $33.24 $143,901 - $270,241
8,130 Added 2.17%
383,129 $7.15 Million
Q4 2022

Feb 13, 2023
BUY
$10.25 - $22.43 $199,577 - $436,734
19,471 Added 5.48%
374,999 $8.05 Million
Q3 2022

Nov 14, 2022
BUY
$11.19 - $17.89 $132,377 - $211,638
11,830 Added 3.44%
355,528 $4.2 Million
Q2 2022

Aug 12, 2022
BUY
$9.03 - $21.55 $289,962 - $691,992
32,111 Added 10.31%
343,698 $4.54 Million
Q1 2022

May 13, 2022
BUY
$15.0 - $22.83 $154,350 - $234,920
10,290 Added 3.42%
311,587 $6.52 Million
Q4 2021

Feb 11, 2022
BUY
$20.12 - $35.09 $85,670 - $149,413
4,258 Added 1.43%
301,297 $6.13 Million
Q3 2021

Nov 12, 2021
BUY
$23.84 - $32.03 $482,044 - $647,646
20,220 Added 7.3%
297,039 $9.02 Million
Q2 2021

Aug 13, 2021
BUY
$29.06 - $38.83 $702,641 - $938,870
24,179 Added 9.57%
276,819 $8.04 Million
Q1 2021

May 12, 2021
BUY
$39.04 - $64.6 $1.11 Million - $1.83 Million
28,403 Added 12.67%
252,640 $10.9 Million
Q4 2020

Feb 12, 2021
BUY
$42.46 - $56.58 $767,804 - $1.02 Million
18,083 Added 8.77%
224,237 $10.4 Million
Q3 2020

Nov 13, 2020
BUY
$37.44 - $64.63 $1.68 Million - $2.89 Million
44,770 Added 27.74%
206,154 $8.94 Million
Q2 2020

Aug 13, 2020
BUY
$17.62 - $58.71 $454,684 - $1.52 Million
25,805 Added 19.03%
161,384 $8.55 Million
Q1 2020

May 14, 2020
BUY
$12.26 - $41.14 $691,157 - $2.32 Million
56,375 Added 71.18%
135,579 $3.03 Million
Q4 2019

Feb 13, 2020
BUY
$4.05 - $14.61 $70,044 - $252,679
17,295 Added 27.94%
79,204 $1.16 Million
Q3 2019

Nov 12, 2019
BUY
$7.04 - $11.77 $10,320 - $17,254
1,466 Added 2.43%
61,909 $435,000
Q2 2019

Aug 14, 2019
BUY
$8.99 - $11.79 $315,557 - $413,840
35,101 Added 138.51%
60,443 $662,000
Q1 2019

May 14, 2019
BUY
$3.49 - $10.47 $88,443 - $265,330
25,342 New
25,342 $250,000

Others Institutions Holding BTAI

# of Institutions
77
Shares Held
6.6M
Call Options Held
85K
Put Options Held
221K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $35.9M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email